title: British HIV Association guidelines for HIV-associated malignancies 2008.
authors.affiliation: Department of Oncology, Chelsea & Westminster Hospital, London, UK. m.bower@imperial.ac.uk
authors.forename: M
authors.initials: M
authors.lastname: Bower
authors.forename: S
authors.initials: S
authors.lastname: Collins
authors.forename: C
authors.initials: C
authors.lastname: Cottrill
authors.forename: K
authors.initials: K
authors.lastname: Cwynarski
authors.forename: S
authors.initials: S
authors.lastname: Montoto
authors.forename: M
authors.initials: M
authors.lastname: Nelson
authors.forename: N
authors.initials: N
authors.lastname: Nwokolo
authors.forename: T
authors.initials: T
authors.lastname: Powles
authors.forename: J
authors.initials: J
authors.lastname: Stebbing
authors.forename: N
authors.initials: N
authors.lastname: Wales
authors.forename: A
authors.initials: A
authors.lastname: Webb
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D016483:Lymphoma, AIDS-Related / Q000175:diagnosis / Q000628:therapy* / Q000821:virology; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D012017:Referral and Consultation; D012514:Sarcoma, Kaposi / Q000175:diagnosis / Q000628:therapy* / Q000821:virology; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000628:therapy* / Q000821:virology